COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (AMEX: CLN) today announced the departure of Anthony P. Deasey, its Chief Financial Officer, effective September 28, 2007. Paul Susie, the company’s controller, will assume the position of interim Chief Accounting Officer and the responsibilities of the company’s financial officer.
“With the completion of our restructuring, Tony’s responsibilities have been substantially reduced and as a result we have agreed that he will pursue other interests. Celsion owes a great deal to Tony for his seven years of service. Most recently, he has helped our company make the transition to an enterprise focused on and dedicated to the development and commercialization of oncology drugs,” commented Michael H. Tardugno, Celsion’s President and CEO. “His contributions have been significant, and we wish him well in his future endeavors.”
